Purchases and Sales Made in Q4 2021 in Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN) during Q4 2021. The information is specifically focused on institutions that hold shares of NeuroSense Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Hudson Bay Capital Management LP
Greenwich, CT |
BUY
|
- |
75KNew |
$180K - $303K
|
75K
$83.3K
|
|
|
Feb 14, 2022
Q4 2021
|
Warberg Asset Management LLC
Winnetka, IL |
BUY
|
- |
15.5KNew |
$37.2K - $62.6K
|
15.5K
$17.2K
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
8.02KNew |
$19.2K - $32.4K
|
8.02K
$8.9K
|
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.32KNew |
$3.18K - $5.34K
|
1.32K
$1.47K
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|